Douglas Emmet Drachman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug-Eluting Stents | 6 | 2021 | 753 | 1.360 |
Why?
|
| Angioplasty, Balloon | 5 | 2019 | 653 | 1.330 |
Why?
|
| Peripheral Arterial Disease | 13 | 2021 | 1184 | 1.280 |
Why?
|
| Lower Extremity | 7 | 2019 | 1151 | 1.050 |
Why?
|
| Ischemia | 6 | 2023 | 1911 | 1.040 |
Why?
|
| Femoral Artery | 4 | 2019 | 843 | 1.000 |
Why?
|
| Stents | 12 | 2017 | 3276 | 0.980 |
Why?
|
| Cardiology | 9 | 2021 | 1658 | 0.970 |
Why?
|
| Limb Salvage | 4 | 2023 | 433 | 0.860 |
Why?
|
| Radial Artery | 3 | 2019 | 194 | 0.680 |
Why?
|
| Popliteal Artery | 3 | 2019 | 317 | 0.660 |
Why?
|
| Veins | 1 | 2023 | 769 | 0.650 |
Why?
|
| Coronary Restenosis | 3 | 2009 | 424 | 0.650 |
Why?
|
| Endovascular Procedures | 8 | 2021 | 1973 | 0.650 |
Why?
|
| Vascular Diseases | 3 | 2017 | 1155 | 0.650 |
Why?
|
| Arteries | 1 | 2023 | 1118 | 0.620 |
Why?
|
| Extremities | 1 | 2023 | 865 | 0.600 |
Why?
|
| Education, Medical, Continuing | 2 | 2021 | 839 | 0.600 |
Why?
|
| Education, Distance | 1 | 2021 | 251 | 0.590 |
Why?
|
| Tunica Intima | 2 | 2014 | 464 | 0.590 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2017 | 314 | 0.580 |
Why?
|
| Cholecystitis | 1 | 2017 | 182 | 0.570 |
Why?
|
| Congresses as Topic | 1 | 2021 | 764 | 0.560 |
Why?
|
| Paclitaxel | 4 | 2021 | 1707 | 0.550 |
Why?
|
| Coronary Angiography | 5 | 2020 | 4567 | 0.540 |
Why?
|
| Cholelithiasis | 1 | 2017 | 411 | 0.540 |
Why?
|
| Gallbladder | 1 | 2017 | 301 | 0.540 |
Why?
|
| Cardiovascular Agents | 2 | 2021 | 848 | 0.540 |
Why?
|
| Ankle Brachial Index | 1 | 2015 | 154 | 0.510 |
Why?
|
| Renal Artery Obstruction | 2 | 2013 | 248 | 0.480 |
Why?
|
| Hemorrhage | 3 | 2019 | 3461 | 0.470 |
Why?
|
| Coronary Artery Disease | 7 | 2019 | 6454 | 0.450 |
Why?
|
| Intestine, Large | 1 | 2012 | 71 | 0.440 |
Why?
|
| Vena Cava Filters | 1 | 2015 | 252 | 0.430 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2014 | 319 | 0.430 |
Why?
|
| Splanchnic Circulation | 1 | 2012 | 110 | 0.430 |
Why?
|
| Angioplasty | 2 | 2012 | 364 | 0.420 |
Why?
|
| Inservice Training | 1 | 2015 | 392 | 0.420 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2012 | 97 | 0.420 |
Why?
|
| Certification | 1 | 2015 | 423 | 0.400 |
Why?
|
| Renal Artery | 1 | 2013 | 398 | 0.380 |
Why?
|
| American Heart Association | 5 | 2018 | 1055 | 0.370 |
Why?
|
| Device Removal | 1 | 2015 | 652 | 0.370 |
Why?
|
| Chest Pain | 1 | 2017 | 1113 | 0.360 |
Why?
|
| Coronary Occlusion | 1 | 2013 | 303 | 0.360 |
Why?
|
| Cardiac Tamponade | 1 | 2010 | 173 | 0.350 |
Why?
|
| Radiography, Interventional | 2 | 2014 | 1095 | 0.340 |
Why?
|
| Vascular Surgical Procedures | 2 | 2015 | 1473 | 0.340 |
Why?
|
| Advisory Committees | 4 | 2017 | 773 | 0.330 |
Why?
|
| Myocardial Ischemia | 2 | 2017 | 2145 | 0.330 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2014 | 1873 | 0.330 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2010 | 125 | 0.330 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 246 | 0.320 |
Why?
|
| Coronary Stenosis | 1 | 2014 | 834 | 0.320 |
Why?
|
| Exercise Test | 1 | 2015 | 2075 | 0.310 |
Why?
|
| Carotid Stenosis | 4 | 2016 | 854 | 0.300 |
Why?
|
| Recombinant Proteins | 2 | 2016 | 6608 | 0.290 |
Why?
|
| Coronary Vessels | 2 | 2015 | 3099 | 0.280 |
Why?
|
| Carotid Artery Diseases | 1 | 2012 | 882 | 0.280 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 1237 | 0.270 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2006 | 54 | 0.270 |
Why?
|
| Catheterization, Peripheral | 2 | 2019 | 344 | 0.260 |
Why?
|
| Vena Cava, Superior | 1 | 2006 | 194 | 0.260 |
Why?
|
| Treatment Outcome | 20 | 2021 | 62966 | 0.240 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 2370 | 0.220 |
Why?
|
| Disease Management | 4 | 2017 | 2450 | 0.210 |
Why?
|
| Clinical Competence | 3 | 2015 | 4681 | 0.190 |
Why?
|
| Humans | 55 | 2023 | 742088 | 0.180 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2017 | 550 | 0.180 |
Why?
|
| Drug Delivery Systems | 2 | 2002 | 2217 | 0.180 |
Why?
|
| Societies, Medical | 4 | 2020 | 3740 | 0.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 15108 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 7276 | 0.150 |
Why?
|
| Registries | 4 | 2019 | 8077 | 0.150 |
Why?
|
| Endarterectomy | 1 | 2017 | 195 | 0.140 |
Why?
|
| Embolic Protection Devices | 1 | 2016 | 42 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3428 | 0.140 |
Why?
|
| Constriction, Pathologic | 2 | 2017 | 1095 | 0.140 |
Why?
|
| Balloon Occlusion | 1 | 2016 | 126 | 0.140 |
Why?
|
| Myocardial Infarction | 2 | 2014 | 11690 | 0.130 |
Why?
|
| Hirudins | 1 | 2016 | 182 | 0.130 |
Why?
|
| Intracranial Embolism | 1 | 2016 | 202 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2002 | 2038 | 0.120 |
Why?
|
| Consensus | 6 | 2019 | 2935 | 0.120 |
Why?
|
| Patient Readmission | 2 | 2018 | 3111 | 0.120 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 974 | 0.110 |
Why?
|
| Databases, Factual | 3 | 2018 | 7716 | 0.110 |
Why?
|
| Equipment Failure | 1 | 2015 | 579 | 0.110 |
Why?
|
| Acute Coronary Syndrome | 2 | 2018 | 2337 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2016 | 409 | 0.110 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2015 | 489 | 0.110 |
Why?
|
| Cerebral Revascularization | 1 | 2015 | 238 | 0.110 |
Why?
|
| Tomography, Emission-Computed | 2 | 2015 | 1144 | 0.110 |
Why?
|
| Nuclear Medicine | 1 | 2015 | 233 | 0.110 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1991 | 32 | 0.110 |
Why?
|
| Male | 19 | 2020 | 349538 | 0.110 |
Why?
|
| Electric Countershock | 1 | 2015 | 535 | 0.110 |
Why?
|
| Heart Diseases | 2 | 2015 | 2789 | 0.100 |
Why?
|
| 4-Aminopyridine | 1 | 1991 | 81 | 0.100 |
Why?
|
| Coronary Aneurysm | 1 | 2014 | 237 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1483 | 0.100 |
Why?
|
| Academies and Institutes | 1 | 2013 | 317 | 0.100 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2015 | 846 | 0.100 |
Why?
|
| Heparin | 2 | 2016 | 1636 | 0.100 |
Why?
|
| Electrocardiography | 2 | 2017 | 6440 | 0.100 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 5724 | 0.090 |
Why?
|
| Cross Infection | 1 | 2020 | 1413 | 0.090 |
Why?
|
| Time Factors | 11 | 2021 | 40054 | 0.090 |
Why?
|
| Endarterectomy, Carotid | 1 | 2015 | 546 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2017 | 3067 | 0.090 |
Why?
|
| Hypertension, Renovascular | 1 | 2009 | 123 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2018 | 1780 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2018 | 1181 | 0.080 |
Why?
|
| Female | 18 | 2020 | 379592 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 1384 | 0.080 |
Why?
|
| Sirolimus | 2 | 2009 | 1562 | 0.080 |
Why?
|
| Potassium Channels | 1 | 1991 | 562 | 0.080 |
Why?
|
| Lidocaine | 1 | 1991 | 542 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 1991 | 1135 | 0.080 |
Why?
|
| Bupivacaine | 1 | 1991 | 408 | 0.080 |
Why?
|
| Pipecolic Acids | 1 | 2008 | 76 | 0.080 |
Why?
|
| Risk Factors | 12 | 2021 | 72145 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6483 | 0.070 |
Why?
|
| Equipment Design | 1 | 2015 | 3582 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2017 | 5978 | 0.070 |
Why?
|
| Communication | 1 | 2021 | 3728 | 0.070 |
Why?
|
| Alcoholism | 1 | 2017 | 1904 | 0.070 |
Why?
|
| Acute Disease | 1 | 2017 | 7141 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2195 | 0.070 |
Why?
|
| Education, Medical, Graduate | 2 | 2015 | 2283 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 2536 | 0.070 |
Why?
|
| United States | 14 | 2021 | 69693 | 0.070 |
Why?
|
| Coronary Disease | 1 | 2000 | 6078 | 0.070 |
Why?
|
| Curriculum | 2 | 2015 | 3589 | 0.070 |
Why?
|
| Inflammation | 1 | 2005 | 10578 | 0.060 |
Why?
|
| Phlebography | 1 | 2006 | 333 | 0.060 |
Why?
|
| Vascular Patency | 2 | 2019 | 885 | 0.060 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 15056 | 0.060 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 1618 | 0.060 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 57683 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5095 | 0.060 |
Why?
|
| Hemodynamics | 2 | 2010 | 4197 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2015 | 3801 | 0.060 |
Why?
|
| Stroke | 3 | 2015 | 9963 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2016 | 3258 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 12958 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2015 | 2746 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2005 | 4147 | 0.050 |
Why?
|
| Patient Selection | 3 | 2018 | 4214 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1171 | 0.050 |
Why?
|
| Ulnar Artery | 1 | 2019 | 17 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8328 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 2059 | 0.040 |
Why?
|
| Swine | 1 | 2009 | 5934 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2018 | 15244 | 0.040 |
Why?
|
| Laboratories, Hospital | 1 | 2020 | 194 | 0.040 |
Why?
|
| Models, Animal | 1 | 2005 | 2170 | 0.040 |
Why?
|
| Critical Illness | 2 | 2021 | 2665 | 0.040 |
Why?
|
| Hospital Mortality | 3 | 2020 | 5310 | 0.040 |
Why?
|
| Animals | 6 | 2014 | 168561 | 0.040 |
Why?
|
| Incidence | 4 | 2018 | 20928 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 372 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2019 | 596 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2014 | 23320 | 0.040 |
Why?
|
| Hand | 1 | 2021 | 882 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 1995 | 51 | 0.030 |
Why?
|
| Arrestins | 1 | 1995 | 74 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2019 | 793 | 0.030 |
Why?
|
| Credentialing | 1 | 2015 | 126 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1788 | 0.030 |
Why?
|
| Mentors | 1 | 2020 | 630 | 0.030 |
Why?
|
| Polymers | 1 | 2002 | 1618 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2021 | 77098 | 0.030 |
Why?
|
| Recurrence | 2 | 2009 | 8333 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2017 | 778 | 0.030 |
Why?
|
| Rabbits | 1 | 2000 | 4886 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2017 | 594 | 0.030 |
Why?
|
| Aged | 8 | 2018 | 162944 | 0.030 |
Why?
|
| Algorithms | 1 | 2014 | 13853 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1839 | 0.030 |
Why?
|
| Antithrombins | 1 | 2016 | 304 | 0.030 |
Why?
|
| Benchmarking | 1 | 2019 | 1038 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1995 | 491 | 0.030 |
Why?
|
| Morbidity | 1 | 2018 | 1767 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2008 | 4595 | 0.030 |
Why?
|
| Schools | 1 | 2021 | 1425 | 0.030 |
Why?
|
| Models, Educational | 1 | 2015 | 377 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4455 | 0.030 |
Why?
|
| Tetraethylammonium | 1 | 1991 | 58 | 0.030 |
Why?
|
| Rana catesbeiana | 1 | 1991 | 86 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 20086 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 1991 | 119 | 0.030 |
Why?
|
| Comorbidity | 2 | 2017 | 10372 | 0.020 |
Why?
|
| Solutions | 1 | 1991 | 426 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39004 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 970 | 0.020 |
Why?
|
| Leadership | 1 | 2020 | 1357 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2012 | 546 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18006 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 2015 | 817 | 0.020 |
Why?
|
| Inpatients | 1 | 2021 | 2495 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 9941 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2009 | 205 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2014 | 681 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2015 | 1206 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 213712 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 1991 | 609 | 0.020 |
Why?
|
| Teaching | 1 | 2015 | 1174 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5171 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3510 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10248 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 2110 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 2156 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 7901 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3611 | 0.020 |
Why?
|
| Arginine | 1 | 2008 | 944 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12773 | 0.020 |
Why?
|
| Action Potentials | 1 | 1991 | 1814 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2015 | 2055 | 0.010 |
Why?
|
| Middle Aged | 5 | 2017 | 213127 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 13019 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9846 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3239 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12242 | 0.010 |
Why?
|
| Logistic Models | 1 | 2014 | 13403 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2008 | 1932 | 0.010 |
Why?
|
| Radiography | 1 | 2009 | 7010 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2013 | 9144 | 0.010 |
Why?
|
| beta-Adrenergic Receptor Kinases | 1 | 1995 | 9 | 0.010 |
Why?
|
| Bucladesine | 1 | 1995 | 121 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1995 | 821 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 7167 | 0.010 |
Why?
|
| Cricetulus | 1 | 1995 | 817 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 85649 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29010 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1995 | 644 | 0.010 |
Why?
|
| Cricetinae | 1 | 1995 | 2471 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 2892 | 0.010 |
Why?
|
| Antigens | 1 | 1995 | 1462 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 53187 | 0.000 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 1984 | 90 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1995 | 8436 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12797 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 1984 | 7988 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13814 | 0.000 |
Why?
|
| Gene Expression | 1 | 1995 | 7790 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 18112 | 0.000 |
Why?
|
| Psychological Tests | 1 | 1984 | 648 | 0.000 |
Why?
|
| Cell Line | 1 | 1995 | 15994 | 0.000 |
Why?
|